Atossa Genetics

ATOS NASDAQ
2.110
+0.040
+1.93%
交易中 15:06 06/18 EDT
开盘
2.050
昨收
2.070
最高
2.120
最低
2.050
成交量
9.84万
成交均量(3M)
88.97万
52周最高
7.39
52周最低
0.8000
换手率
1.08%
市值
1,925.32万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Atossa Genetics ATOS股票价格,Atossa Genetics股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Atossa Genetics Inc. is a clinical-stage pharmaceutical company focused on the development of therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The Company's leading program uses its intraductal microcatheters, which deliver pharmaceuticals through the breast ducts. It has initiated a Phase II clinical study using its microcatheters to deliver fulvestrant as a treatment of ductal carcinoma in-situ (DCIS) and breast cancer. Its second pharmaceutical program under development is Afimoxifene Topical Gel (AfTG) for the treatment and prevention of hyperplasia of the breast. It is also engaged in the process of evaluating other therapeutic candidates to treat other breast conditions, including breast cancer. Its medical devices include the ForeCYTE Breast Aspirator and the FullCYTE Breast Aspirator. These devices are intended for the collection of nipple aspirate fluid (NAF) for cytological testing at a laboratory.
展开 >

最近浏览

名称
价格
涨跌幅